Tumor avatars could personalize chemo for kids with rare cancers
NCT ID NCT07528079
First seen Apr 19, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study tests whether growing a child's tumor cells in the lab (called organoids) can help doctors pick the most effective chemotherapy. It includes 30 children aged 1 to 18 with certain soft tissue sarcomas that have come back or not responded to prior treatment. The goal is to see if this personalized approach leads to better tumor shrinkage and longer control of the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA, CHILD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200127, China
Conditions
Explore the condition pages connected to this study.